August 23, 2021
HUTCHMED Selected as Constituent of Certain Hang Seng Indexes
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Aug. 22, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:…
Pharmaceuticals, Biotechnology and Life Sciences
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Aug. 22, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:…
One-time treatment option during surgery ideal for patients over 70 who may otherwise receive no radiation or endure side effects…
Data shows that the administration of Rhenium-186 NanoLiposome (186RNL) via convection enhanced delivery for recurrent glioblastoma is well tolerated at…
Immunization with a protein-based immunogen, DYAI-100, a receptor binding domain (RBD) of SARS-CoV-2, resulted in potent B cell immunity in…
Roxadustat is the first orally administered hypoxia-inducible factor (HIF) prolyl hydroxylase (PH) inhibitor available for adult patients with anemia associated…
-Program helps those living with Achromatopsia receive filtered glasses and contact lenses to qualify for bioptic driving- GAINESVILLE, Fla., and…
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, announced today that…
10 of 14 Patients in FT596 Single-Dose Escalation Cohorts 2 and 3 Achieved Objective Response; 7 Patients Achieved Complete Response,…
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a…
ZUG, Switzerland, Aug. 19, 2021 (GLOBE NEWSWIRE) — Covis Group S.à r.l. (“Covis”) announced today that the U.S. Food and Drug…